Morgan Stanley initiated coverage of Option Care Health (OPCH) with an Overweight rating and $35 price target The company is well positioned amid rising prevalence of chronic disease and focus on lower-cost care centers, the analyst tells investors in a research note. The firm says Option Care is a leader in the home and alternative-site infusion market, offering a critical solution to the healthcare system.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OPCH:
- Option Care Health: Positioned for Growth in the Expanding Infusion Market
- These 3 “Strong Buy” Value Stocks Have over 20% Upside, According to Analysts – 10/14/2025
- Option Care Health: Strong Market Position and Financials Balanced by Lack of Near-Term Catalysts
- Option Care Health initiated with a Hold at TD Cowen
- Option Care Health Amends Credit Agreement for Refinancing